logo

Global Veterinary Healthcare Market Outlook to 2028

Region:Global

Author(s):Mukul

Product Code:KROD9753

Download Sample Report
Published On

December 2024

Total pages

84

About the Report

Global Veterinary Healthcare Market Overview

  • The global veterinary healthcare market is valued at USD 43.2 billion, based on a five-year historical analysis. The market is driven by the increasing pet ownership globally, growing awareness of animal health, and rising demand for preventive care services for pets and livestock. Advances in veterinary diagnostics and pharmaceuticals, coupled with increasing expenditure on pet healthcare, are significant drivers boosting market growth.
  • Countries such as the United States, Germany, and Australia dominate the veterinary healthcare market due to their high pet ownership rates and well-established veterinary infrastructure. The U.S., for example, has a significant number of veterinary hospitals and clinics, supported by government initiatives that focus on improving animal health. In Germany, the rise in livestock farming and demand for veterinary services further fuels the market's dominance.
  • Governments globally are strengthening animal welfare laws to protect livestock and companion animals. In 2023, the European Union revised its animal welfare regulations, mandating more stringent living conditions for livestock, such as larger enclosures and improved veterinary oversight. In the U.S., the Animal Welfare Act continues to enforce strict standards for animal care in research, exhibition, and transport. Such laws are essential for ensuring animal health, but they also place additional responsibilities on veterinary healthcare providers.

Global Veterinary Healthcare Market Segmentation

  • By Product Type: The global veterinary healthcare market is segmented by product type into pharmaceuticals, diagnostics, and veterinary equipment. Recently, the pharmaceutical segment, including antibiotics, vaccines, and antiparasitic drugs, has taken the dominant share. This dominance is attributed to the increasing prevalence of zoonotic diseases and the growing focus on preventive veterinary care. Additionally, vaccines have witnessed a surge in demand due to regulatory emphasis on the prevention of diseases in livestock, which impacts both animal and human health.
  • By Region: The market is also segmented by region, with North America, Europe, Asia Pacific, Latin America, and Middle East & Africa being the key regions. North America dominates the market, driven by a combination of factors such as the high prevalence of pet ownership, the existence of a sophisticated veterinary healthcare infrastructure, and the availability of advanced veterinary diagnostics. The U.S. remains a leader in veterinary pharmaceutical innovations and regulatory approvals, while Canada contributes significantly through livestock healthcare advancements.
  • By Animal Type: The veterinary healthcare market is further segmented by animal type into companion animals and livestock animals. Companion animals, particularly dogs and cats, hold a significant share of the market. This dominance is driven by the rising trend of pet humanization, where owners view pets as family members and are willing to invest heavily in their health. The demand for companion animal healthcare is also fueled by increasing urbanization and rising disposable incomes, especially in developing economies.

Global Veterinary Healthcare Market Competitive Landscape

The global veterinary healthcare market is characterized by the presence of several key players. These companies engage in continuous product innovation and strategic mergers & acquisitions to strengthen their market position. The market is consolidated, with top companies contributing a major share of the overall revenue.

Company

Established Year

Headquarters

No. of Employees

R&D Spend (USD)

Global Reach

Product Portfolio

Revenue (USD Bn)

Zoetis Inc.

1952

U.S.

-

-

-

-

-

Merck Animal Health

1891

U.S.

-

-

-

-

-

Elanco Animal Health

1954

U.S.

-

-

-

-

-

Boehringer Ingelheim

1885

Germany

-

-

-

-

-

IDEXX Laboratories, Inc.

1983

U.S.

-

-

-

-

-

Global Veterinary Healthcare Industry Analysis

Growth Drivers

  • Companion Animal Ownership: Companion animal ownership has seen significant growth worldwide, driven by changing lifestyles and an increased focus on animal welfare. The United States is a prime example, where over 90 million households own pets as of 2024, according to the American Pet Products Association. This trend is echoed in Europe and emerging markets like Brazil, where pet ownership is also rising due to increasing disposable incomes and urbanization. Additionally, China reported an increase in pet ownership to 54 million households in 2023, highlighting the global expansion of this trend. This increasing pet population drives demand for veterinary services.
  • Rising Demand for Livestock Healthcare: The global livestock population is expanding to meet the increasing demand for animal protein. According to the FAO, in 2023, the worlds cattle population stood at 1.5 billion, while the number of pigs was approximately 1 billion. With the growth of livestock comes heightened demand for veterinary healthcare services to ensure animal welfare and production efficiency. In India, one of the largest livestock economies, the National Dairy Development Board reported 303 million cattle in 2022. This growing livestock population emphasizes the need for robust veterinary healthcare services globally.
  • Advancements in Animal Health Diagnostics (Technological Adoption): The veterinary healthcare sector is benefiting from significant technological advancements in diagnostics. The use of molecular diagnostics, imaging technologies, and AI-driven diagnostic tools is improving the accuracy and efficiency of animal healthcare. In 2024, the FDA approved more than 45 new diagnostic tools that use AI and machine learning, enhancing disease detection and treatment outcomes in veterinary care. These innovations are primarily aimed at reducing diagnostic time and improving early detection rates in animals, further pushing the market towards more advanced and efficient healthcare solutions.

Market Restraints

  • High Cost of Veterinary Diagnostics: One of the major challenges in veterinary healthcare is the rising cost of diagnostic procedures. According to data from the AVMA (American Veterinary Medical Association), the cost of advanced diagnostics like MRI scans for pets ranges between $1,500 and $3,000 per procedure in 2024. These high costs are a barrier to wider adoption, especially for lower-income pet owners and livestock farmers in developing countries. Even routine blood tests and X-rays, which cost around $200 to $500, can be prohibitively expensive for many. This cost challenge limits access to timely healthcare for animals globally.
  • Stringent Regulatory Approvals: The veterinary pharmaceutical sector faces stringent regulatory requirements, which slows the introduction of new drugs and treatments. For instance, the European Medicines Agency (EMA) approved only 20 new veterinary medicinal products in 2023, reflecting the time-consuming nature of regulatory processes. These regulations are essential for ensuring animal safety but can delay access to vital treatments, particularly for emerging diseases. The U.S. FDA also reported a significant backlog of veterinary drug approvals in 2024, citing complex safety evaluations as a reason for delays.

Global Veterinary Healthcare Market Future Outlook

Over the next five years, the global veterinary healthcare market is expected to show significant growth, driven by advancements in animal diagnostics, growing awareness of zoonotic diseases, and the increasing integration of telemedicine in veterinary care. The adoption of digital tools for veterinary diagnostics, paired with emerging markets showing high demand for livestock healthcare, will likely further accelerate market expansion. Companies are also expected to focus on increasing access to veterinary care in underserved regions, enhancing both companion and livestock animal healthcare.

Market Opportunities

  • Growth of Veterinary Telehealth Services: Telemedicine has emerged as a significant opportunity in the veterinary healthcare market, offering a solution to both high costs and access issues. In 2024, more than 12,000 veterinary clinics in the U.S. and Europe offer telehealth services, which have proven effective in diagnosing common ailments and reducing the need for in-person visits. Telehealth platforms, such as VetNow, reported a 30% increase in usage in 2023, as pet owners seek more affordable and convenient veterinary consultations. This trend is expected to improve access, especially in underserved areas.
  • Expansion into Developing Markets: Developing markets in Asia, Africa, and Latin America represent untapped opportunities for veterinary healthcare providers. The African Union's 2024 veterinary report highlights the growing demand for animal healthcare in countries like Nigeria and Kenya, driven by expanding livestock populations and increasing investment in animal husbandry. In India, where the livestock population reached 536 million in 2022, government initiatives are driving the development of veterinary services. These emerging markets offer opportunities for companies to expand their presence and introduce advanced healthcare solutions.

Scope of the Report

Product Type

Pharmaceuticals

Diagnostics

Veterinary Equipment

Animal Type

Companion Animals

Livestock Animals

Route of Administration

Oral

Parenteral

Topical

End User

Veterinary Clinics

Animal Hospitals

Research Institutes

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Products

Key Target Audience

  • Veterinary Clinics and Hospitals
  • Pet Owners and Livestock Farmers
  • Pharmaceutical Companies
  • Animal Health Diagnostic Companies
  • Research Institutes and Laboratories
  • Government and Regulatory Bodies (FDA, USDA)
  • Investor and Venture Capitalist Firms
  • Animal Welfare Organizations

Companies

Players Mentioned in the Report:

  • Zoetis Inc.
  • Merck Animal Health
  • Elanco Animal Health
  • Boehringer Ingelheim
  • IDEXX Laboratories, Inc.
  • Virbac
  • Ceva Sant Animale
  • Vetoquinol
  • Dechra Pharmaceuticals
  • Neogen Corporation
  • Heska Corporation
  • Bayer Animal Health
  • Phibro Animal Health Corporation
  • Patterson Companies, Inc.
  • Covetrus, Inc.

Table of Contents

1. Global Veterinary Healthcare Market Overview

1.1 Definition and Scope

1.2 Market Taxonomy (Companion Animal Care, Livestock Care, Pet Health, Animal Vaccination)

1.3 Market Growth Rate (CAGR, Market Size Increase, Market Demand)

1.4 Market Segmentation Overview

2. Global Veterinary Healthcare Market Size (In USD Bn)

2.1 Historical Market Size (In USD Bn)

2.2 Year-on-Year Growth Analysis (Revenue Growth, Demand Fluctuation)

2.3 Key Market Developments and Milestones (Regulatory Milestones, Major Innovations)

3. Global Veterinary Healthcare Market Analysis

3.1 Growth Drivers (Increased Pet Ownership, Rising Livestock Population, Technological Advancements in Animal Diagnostics)

3.1.1 Companion Animal Ownership

3.1.2 Rising Demand for Livestock Healthcare

3.1.3 Advancements in Animal Health Diagnostics (Technological Adoption)

3.1.4 Government Initiatives and Animal Welfare Policies

3.2 Market Challenges (High Cost of Veterinary Services, Regulatory Barriers, Shortage of Veterinarians)

3.2.1 High Cost of Veterinary Diagnostics

3.2.2 Stringent Regulatory Approvals

3.2.3 Limited Access to Veterinary Healthcare in Rural Areas

3.3 Opportunities (Telemedicine, Digital Veterinary Services, Emerging Markets)

3.3.1 Growth of Veterinary Telehealth Services

3.3.2 Expansion into Developing Markets

3.3.3 Collaboration with Pharmaceutical Companies

3.4 Trends (Preventive Healthcare, Personalized Animal Medicine, Rise in Pet Insurance)

3.4.1 Rise of Personalized Veterinary Medicine

3.4.2 Increasing Popularity of Pet Insurance

3.4.3 Growth in Preventive Veterinary Care

3.5 Government Regulation (FDA Approvals, Animal Drug Availability Act, Animal Health Laws)

3.5.1 FDA Approvals for Veterinary Pharmaceuticals

3.5.2 Animal Welfare Laws and Regulations

3.5.3 Veterinary Pharmaceutical Availability Regulations

3.6 SWOT Analysis

3.7 Stakeholder Ecosystem (Veterinary Clinics, Pharmaceuticals, Animal Health Diagnostic Companies, Livestock Farmers)

3.8 Porters Five Forces (Supplier Power, Buyer Power, Competitive Rivalry, Threat of Substitution, Barriers to Entry)

3.9 Competition Ecosystem (Top Players, Market Penetration, Distribution Channels)

4. Global Veterinary Healthcare Market Segmentation

4.1 By Product Type (In Value %)

4.1.1 Pharmaceuticals (Antibiotics, Vaccines, Anti-parasitics)

4.1.2 Diagnostics (In-house Testing, Diagnostic Imaging, Molecular Diagnostics)

4.1.3 Veterinary Equipment (Surgical Instruments, Monitoring Devices, Imaging Systems)

4.2 By Animal Type (In Value %)

4.2.1 Companion Animals (Dogs, Cats, Horses)

4.2.2 Livestock Animals (Cattle, Poultry, Swine)

4.3 By Route of Administration (In Value %)

4.3.1 Oral Administration

4.3.2 Parenteral Administration

4.3.3 Topical Administration

4.4 By End User (In Value %)

4.4.1 Veterinary Clinics

4.4.2 Animal Hospitals

4.4.3 Research Institutes

4.5 By Region (In Value %)

4.5.1 North America

4.5.2 Europe

4.5.3 Asia Pacific

4.5.4 Latin America

4.5.5 Middle East & Africa

5. Global Veterinary Healthcare Market Competitive Analysis

5.1 Detailed Profiles of Major Companies

5.1.1 Zoetis Inc.

5.1.2 Merck Animal Health

5.1.3 Elanco Animal Health

5.1.4 Boehringer Ingelheim

5.1.5 Ceva Sant Animale

5.1.6 Vetoquinol

5.1.7 IDEXX Laboratories, Inc.

5.1.8 Virbac

5.1.9 Phibro Animal Health Corporation

5.1.10 Heska Corporation

5.1.11 Dechra Pharmaceuticals

5.1.12 Bayer Animal Health

5.1.13 Patterson Companies, Inc.

5.1.14 Covetrus, Inc.

5.1.15 Neogen Corporation

5.2 Cross Comparison Parameters (Market Presence, Product Portfolio, Annual Revenue, Number of Patents, Innovation Capacity, Global Footprint, R&D Spend, Strategic Partnerships)

5.3 Market Share Analysis

5.4 Strategic Initiatives (New Product Launches, Mergers & Acquisitions, Collaborations)

5.5 Mergers and Acquisitions (Key Deals, Financial Impact)

5.6 Investment Analysis (Private Equity, Venture Capital)

5.7 Government Grants

5.8 Venture Capital Funding

5.9 Private Equity Investments

6. Global Veterinary Healthcare Market Regulatory Framework

6.1 FDA Regulations

6.2 Compliance and Certification Standards

6.3 Veterinary Drug Approval Processes

7. Global Veterinary Healthcare Market Future Size (In USD Bn)

7.1 Future Market Size Projections

7.2 Key Factors Driving Future Market Growth (Technological Innovations, Expansion into Emerging Markets)

8. Global Veterinary Healthcare Market Future Segmentation

8.1 By Product Type (In Value %)

8.2 By Animal Type (In Value %)

8.3 By Route of Administration (In Value %)

8.4 By End User (In Value %)

8.5 By Region (In Value %)

9. Global Veterinary Healthcare Market Analysts Recommendations

9.1 TAM/SAM/SOM Analysis

9.2 Customer Cohort Analysis

9.3 Marketing Initiatives

9.4 White Space Opportunity Analysis

Disclaimer

Contact Us

Research Methodology

Step 1: Identification of Key Variables

The initial phase involved constructing an ecosystem map encompassing all major stakeholders within the global veterinary healthcare market. This was based on extensive desk research, leveraging a combination of secondary and proprietary databases to gather comprehensive industry-level information. The key variables identified include market demand for veterinary pharmaceuticals, diagnostics, and technological advancements in animal health.

Step 2: Market Analysis and Construction

In this step, historical data on the veterinary healthcare market was analyzed to assess trends in pet ownership, livestock healthcare, and the revenue generated from veterinary pharmaceuticals and diagnostics. An evaluation of technological innovations in veterinary services was also carried out to ensure the accuracy of market projections.

Step 3: Hypothesis Validation and Expert Consultation

Market hypotheses were developed and validated through consultations with industry experts, including leading veterinarians, pharmaceutical executives, and key opinion leaders in animal health. These interviews provided invaluable insights into market growth drivers and industry challenges.

Step 4: Research Synthesis and Final Output

The final phase involved synthesizing data from both top-down and bottom-up approaches, ensuring a comprehensive analysis of the global veterinary healthcare market. Direct engagement with key market players helped refine the overall market structure and dynamics.

 

Frequently Asked Questions

01. How big is the Global Veterinary Healthcare Market?

The global veterinary healthcare market, valued at USD 43.2 billion, is driven by increasing demand for animal healthcare services, coupled with advancements in veterinary diagnostics and pharmaceuticals.

02. What are the challenges in the Global Veterinary Healthcare Market?

Challenges include high costs associated with veterinary diagnostics and pharmaceuticals, a shortage of skilled veterinarians in rural areas, and stringent regulatory approvals, particularly for new drugs and vaccines.

03. Who are the major players in the Global Veterinary Healthcare Market?

Key players in the market include Zoetis Inc., Merck Animal Health, Elanco Animal Health, Boehringer Ingelheim, and IDEXX Laboratories, Inc. These companies dominate due to their extensive product portfolios and strong distribution networks.

04. What are the growth drivers of the Global Veterinary Healthcare Market?

The market is driven by the growing trend of pet humanization, rising awareness of zoonotic diseases, and advancements in animal healthcare technologies such as telemedicine and molecular diagnostics.

 

 

Why Buy From Us?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022